Nothing Special   »   [go: up one dir, main page]

create a website
Determinants of Pharmaceutical Innovation: The Role of Technological Opportunities Revisited. (2013). Rake, Bastian.
In: DRUID Working Papers.
RePEc:aal:abbswp:13-03.

Full description at Econpapers || Download paper

Cited: 0

Citations received by this document

Cites: 59

References cited by this document

Cocites: 50

Documents which have cited the same bibliography

Coauthors: 0

Authors who have wrote about the same topic

Citations

Citations received by this document

    This document has not been cited yet.

References

References cited by this document

  1. Acemoglu, D. and Linn, J. (2004). Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry. The Quarterly Journal of Economics, 119(3):1049–1090.

  2. Adner, R. and Levinthal, D. (2001). Demand Heterogeneity and Technology Evolution: Implications for Product and Process Innovation. Management Science, 47(5):611–628.

  3. Andersen, B. (1998). The Evolution of Technological Trajectories 1890–1990. Structural Change and Economic Dynamics, 9(1):5–34.
    Paper not yet in RePEc: Add citation now
  4. Andersen, B. (1999). The Hunt for S-shaped Growth Paths in Technological Innovation: A Patent Study. Journal of Evolutionary Economics, 9(4):487–526.

  5. Becker, W. and Peters, J. (2000). Technological Opportunities, Absorptive Capacities, and Innovation. Discussion Paper Series, University of Augsburg, Institute for Economics, 195.

  6. Bitzer, J. and Stephan, A. (2007). A Schumpeter-inspired Approach to the Construction of R&D Capital Stocks. Applied Economics, 39(2):179–189.

  7. Blundell, R., Griffith, R., and Reenen, J. V. (1995). Dynamic Count Data Models of Technological Innovation. The Economic Journal, 105(429):333–344.

  8. Blundell, R., Griffith, R., and Windmeijer, F. (2002). Individual Effects and Dynamics in Count Data Models. Journal of Econometrics, 108(1):113–131.

  9. Castellacci, F. (2007). Technological Regimes and Sectoral Differences in Productivity Growth. Industrial and Corporate Change, 16(6):1105–1145.

  10. Cerda, R. A. (2007). Endogenous Innovations in the Pharmaceutical Industry. Journal of Evolutionary Economics, 17(4):473–515.

  11. Cockburn, I. M. and Henderson, R. M. (2001). Scale and Scope in Drug Development: Unpacking the Advantages of Size in Pharmaceutical Research. Journal of Health Economics, 20(6):1033–1057.

  12. Cohen, W. M. and Levin, R. C. (1989). Empirical Studies of Innovation and Market Structure.

  13. Cohen, W. M. and Levinthal, D. A. (1989). Innovation and Learning: The Two Faces of R & D. The Economic Journal, 99(397):569–596.

  14. Cohen, W., Nelson, R., and Walsh, J. (2002). Links and Impacts: The Influence of Public Research on Industrial R&D. Management Science, 48(1):1–23.

  15. DiMasi, J. A. and Grabowski, H. G. (2007). The Cost of Biopharmaceutical R&D: Is Biotech Different? Managerial and Decision Economics, 28(4-5):469–479.
    Paper not yet in RePEc: Add citation now
  16. Dosi, G. (1988). Sources, Procedures, and Microeconomic Effects of Innovation. Journal of Economic Literature, 26(3):1120–1171.
    Paper not yet in RePEc: Add citation now
  17. Freeman, C. (1994). The Economics of Technical Change. Cambridge Journal of Economics, 18(5):463–514.

  18. Galambos, L. and Sturchio, J. L. (1998). Pharmaceutical Firms and the Transition to Biotechnology: A Study in Strategic Innovation. The Business History Review, 72(2):250–278.

  19. Gambardella, A. (1995). Science and Innovation: The U.S. Pharmaceutical Industry During the 1980s. Cambridge University Press, Cambridge et al.

  20. Geroski, P. A. and Walters, C. F. (1995). Innovative Activity over the Business Cycle. The Economic Journal, 105(431):916–928.

  21. Giaccotto, C., Santerre, R. E., and Vernon, J. A. (2005). Drug Prices and Research and Development Investment Behavior in the Pharmaceutical Industry. Journal of Law and Economics, 48(1):195–214.

  22. Gourieroux, C., Monfort, A., and Trognon, A. (1984). Pseudo Maximum Likelihood Methods: Applications to Poisson Models. Econometrica, 52(3):701–720.

  23. Grabowski, H. and Vernon, J. (2000). The Determinants of Pharmaceutical Research and Development Expenditures. Journal of Evolutionary Economics, 10(1-2):201–215.

  24. Grabowski, H. G. (1968). The Determinants of Industrial Research and Development: A Study of the Chemical, Drug, and Petroleum Industries. Journal of Political Economy, 76(2):292–306.

  25. Grabowski, H. G. and Wang, Y. R. (2006). The Quantity and Quality of Worldwide New Drug Introductions 19822003. Health Affairs, 25(2):452–460.
    Paper not yet in RePEc: Add citation now
  26. Grabowski, H. G., Vernon, J. M., and Thomas, L. G. (1978). Estimating the Effects of Regulation on Innovation: An International Comparative Analysis of the Pharmaceutical Industry. Journal of Law and Economics, 21(1):133–163.

  27. Griliches, Z., Hall, B. H., and Pakes, A. (1991). R&D, Patents, and Market Value Revisited: Is There A Second (Technological Opportunity) Factor? Economics of Innovation & New Technology, 1(3):183–201.
    Paper not yet in RePEc: Add citation now
  28. Hamilton, K. S. (2003). Subfield and Level Classification of Journals. CHI Research Inc., CHI No. 2012-R.
    Paper not yet in RePEc: Add citation now
  29. Henderson, R. and Cockburn, I. (1994). Measuring Competence? Exploring Firm Effects in Pharmaceutical Research. Strategic Management Journal, 15:63–84.

  30. In Schmalensee, R. and Willig, R., editors, Handbook of Industrial Organization, pages 1059–1107. Elsevier, Amsterdam et al.
    Paper not yet in RePEc: Add citation now
  31. Jaffe, A. B. (1986). Technological Opportunity and Spillovers of R&D: Evidence from Firms’ Patents, Profits, and Market Value. The American Economic Review, 76(5):984– 1001.
    Paper not yet in RePEc: Add citation now
  32. Jaffe, A. B. (1989a). Characterizing the ’Technological Position’ of Firms, with Application to Quantifying Technological Opportunity and Research Spillovers. Research Policy, 18(2):8–97.
    Paper not yet in RePEc: Add citation now
  33. Kleinknecht, A. and Verspagen, B. (1990). Demand and Innovation: Schmookler Reexamined. Research Policy, 19(4):387–394.
    Paper not yet in RePEc: Add citation now
  34. Klevorick, A. K., Levin, R. C., Nelson, R. R., and Winter, S. G. (1995). On the Sources and Significance of Interindustry Differences in Technological Opportunities. Research Policy, 24(2):185–205.
    Paper not yet in RePEc: Add citation now
  35. Kremer, M. (2002). Pharmaceuticals and the Developing World. Journal of Economic Perspectives, Vol. 16(4):67–90.

  36. Lacy, C., Armstrong, L., Goldman, M., and Lance, L., editors (2010). Drug Information Handbook. Lexi-Comp, Hudson, 19th edition.
    Paper not yet in RePEc: Add citation now
  37. Levin, R. C., Klevorick, A. K., Nelson, R. R., Winter, S. G., Gilbert, R., and Griliches, Z. (1987). Appropriating the Returns from Industrial Research and Development. Brookings Papers on Economic Activity, 1987(3):783–831.

  38. Lichtenberg, F. R. (2004). Sources of U.S. Longevity Increase, 1960–2001. The Quarterly Review of Economics and Finance, 44(3):369–389.
    Paper not yet in RePEc: Add citation now
  39. Lichtenberg, F. R. (2005a). Pharmaceutical Innovation and the Burden of Disease in Developing and Developed Countries. Journal of Medicine and Philosophy, 30(6):663– 690.
    Paper not yet in RePEc: Add citation now
  40. Lichtenberg, F. R. (2005b). The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982–2001. International Journal of Health Care Finance and Economics, 5(1):47–73.
    Paper not yet in RePEc: Add citation now
  41. Lim, K. (2004). The Relationship Between Research and Innovation in the Semiconductor and Pharmaceutical Industries (1981-1997). Research Policy, 33(2):287–321.

  42. Mahlich, J. C. and Roediger-Schluga, T. (2006). The Determinants of Pharmaceutical R&D Expenditures: Evidence from Japan. Review of Industrial Organization, 28(2):145–164.

  43. Malerba, F., Nelson, R., Orsenigo, L., and Winter, S. (2007). Demand, Innovation, and the Dynamics of Market Structure: The Role of Experimental Users and Diverse Preferences. Journal of Evolutionary Economics, 17(4):371–399.

  44. McKelvey, M. (1996). Evolutionary Innovations: The Business of Biotechnology. Oxford University Press, Oxford et al.
    Paper not yet in RePEc: Add citation now
  45. Morton, F. M. S. (1999). Entry Decisions in the Generic Pharmaceutical Industry. The RAND Journal of Economics, 30(3):421–440.

  46. Mowery, D. and Rosenberg, N. (1979). The Influence of Market Demand upon Innovation: A Critical Review of Some Recent Empirical Studies. Research Policy, 8(2):102 – 153.

  47. Nelson, R. R. (1988). Modelling the Connections in the Cross Section between Technical Progress and R&D Intensity. The RAND Journal of Economics, 19(3):478–485.

  48. Nelson, R. R. and Wolff, E. N. (1997). Factors Behind Cross-Industry Differences in Technical Progress. Structural Change and Economic Dynamics, 8(2):205–220.
    Paper not yet in RePEc: Add citation now
  49. Pan, W. (2001). Akaike’s Information Criterion in Generalized Estimating Equations. Biometrics, 57(1):120–125.
    Paper not yet in RePEc: Add citation now
  50. Rasmussen, B. (2010). Innovation and Commercialisation in the Biopharmaceutical Industry: Creating and Capturing Value. Edward Elgar Publishing Ltd, Cheltenham and Northhampton.

  51. Reiffen, D. and Ward, M. R. (2005). Generic Drug Industry Dynamics. Review of Economics and Statistics, 87(1):37–49.

  52. Scherer, F. M. (1965). Firm Size, Market Structure, Opportunity, and the Output of Patented Inventions. The American Economic Review, 55(5):1097–1125.
    Paper not yet in RePEc: Add citation now
  53. Scherer, F. M. (1982). Demand-pull and Technological Invention: Schmookler Revisited. The Journal of Industrial Economics, 30(3):225–237.

  54. Schmookler, J. (1966). Invention and Economic Growth. Harvard University Press, Cambridge.
    Paper not yet in RePEc: Add citation now
  55. Toole, A. (2007). Does Public Scientific Research Complement Private Investment in Research and Development in the Pharmaceutical Industry? The Journal of Law and Economics, 50(1):81–104.

  56. Toole, A. A. (2012). The Impact of Public Basic Research on Industrial Innovation: Evidence from the Pharmaceutical Industry. Research Policy, 41(1):1–12.

  57. von Hippel, E. (1976). The Dominant Role of Users in the Scientific Instrument Innovation Process. Research Policy, 5(3):212–239.
    Paper not yet in RePEc: Add citation now
  58. Walsh, V. (1984). Invention and Innovation in the Chemical Industry: Demand-pull or Discovery-push? Research Policy, 13(4):211–234.

  59. Yin, W. (2008). Market Incentives and Pharmaceutical Innovation. Journal of Health Economics, 27(4):1060–1077.

Cocites

Documents in RePEc which have cited the same bibliography

  1. Financing innovation. (2015). Kerr, William R ; Nanda, Ramana .
    In: Research Discussion Papers.
    RePEc:bof:bofrdp:urn:nbn:fi:bof-201512141480.

    Full description at Econpapers || Download paper

  2. Regulation of the Pharmaceutical-Biotechnology Industry. (2014). Keuffel, Eric ; Danzon, Patricia M..
    In: NBER Chapters.
    RePEc:nbr:nberch:12572.

    Full description at Econpapers || Download paper

  3. Demand Forces of Technical Change Evidence from the Chinese Manufacturing Industry. (2013). Zweimüller, Josef ; Zilibotti, Fabrizio ; Beerli, Andreas ; Zweimuller, Josef ; Weiss, Franziska .
    In: Annual Conference 2013 (Duesseldorf): Competition Policy and Regulation in a Global Economic Order.
    RePEc:zbw:vfsc13:79980.

    Full description at Econpapers || Download paper

  4. Pharmaceutical Portfolio Management: Global Disease Burden and Corporate Performance Metrics. (2013). Edith L. Maes DBA, ; Daems, Rutger P..
    In: Working Papers.
    RePEc:msm:wpaper:2013/07.

    Full description at Econpapers || Download paper

  5. Efficient Self-Protection and Progress in Curing-Technology. (2013). Sorek, Gilad.
    In: Auburn Economics Working Paper Series.
    RePEc:abn:wpaper:auwp2013-07.

    Full description at Econpapers || Download paper

  6. Pharmaceutical patents and prices : a preliminary empirical assessment using data from India. (2012). Goyal, Aparajita ; Duggan, Mark.
    In: Policy Research Working Paper Series.
    RePEc:wbk:wbrwps:6063.

    Full description at Econpapers || Download paper

  7. Induced Innovation and Social Inequality: Evidence from Infant Medical Care. (2012). Richards-Shubik, Seth ; Cutler, David M. ; Meara, Ellen .
    In: Journal of Human Resources.
    RePEc:uwp:jhriss:v:46:y:2012:ii:1:p:456-492.

    Full description at Econpapers || Download paper

  8. The Effect of U.S. Health Insurance Expansions on Medical Innovation. (2012). Clemens, Jeffrey.
    In: Discussion Papers.
    RePEc:sip:dpaper:11-016.

    Full description at Econpapers || Download paper

  9. When More Poor Means Less Poverty: On Income Inequality and Purchasing Power. (2012). Nilsson, Therese ; Bergh, Andreas.
    In: Working Papers.
    RePEc:hhs:lunewp:2012_002.

    Full description at Econpapers || Download paper

  10. When More Poor Means Less Poverty: On Income Inequality and Purchasing Power. (2012). Nilsson, Therese ; Bergh, Andreas.
    In: Working Paper Series.
    RePEc:hhs:iuiwop:0900.

    Full description at Econpapers || Download paper

  11. Carbon Taxes, Path Dependency and Directed Technical Change: Evidence from the Auto Industry. (2012). van Reenen, John ; Martin, Ralf ; Hemous, David ; Dechezleprêtre, Antoine ; Aghion, Philippe ; Dechezlepretre, Antoine ; VanReenen, John .
    In: Working Papers.
    RePEc:fem:femwpa:2012.99.

    Full description at Econpapers || Download paper

  12. The nascent market for “green” real estate in Beijing. (2012). Zheng, Siqi ; Wu, Jing ; Kahn, Matthew ; Deng, Yongheng.
    In: European Economic Review.
    RePEc:eee:eecrev:v:56:y:2012:i:5:p:974-984.

    Full description at Econpapers || Download paper

  13. Technological Intensity of Government Demand and Innovation. (2012). Wiederhold, Simon ; Slavtchev, Viktor.
    In: ifo Working Paper Series.
    RePEc:ces:ifowps:_135.

    Full description at Econpapers || Download paper

  14. Carbon Taxes, Path Dependency and Directed Technical Change: Evidence from the Auto Industry. (2012). van Reenen, John ; Martin, Ralf ; Hemous, David ; Dechezleprêtre, Antoine ; Aghion, Philippe ; Dechezlepretre, Antoine ; VanReenen, John .
    In: CEP Discussion Papers.
    RePEc:cep:cepdps:dp1178.

    Full description at Econpapers || Download paper

  15. The impact of public basic research on industrial innovation: Evidence from the pharmaceutical industry. (2011). Toole, Andrew A..
    In: ZEW Discussion Papers.
    RePEc:zbw:zewdip:11063.

    Full description at Econpapers || Download paper

  16. Market Share Exclusion. (2011). Packalen, Mikko.
    In: Working Papers.
    RePEc:wat:wpaper:1103.

    Full description at Econpapers || Download paper

  17. Endogenous technological change in medicine and its impact on healthcare costs: evidence from the pharmaceutical market in Taiwan. (2011). Chang, Chia-Lin ; Hsieh, Chee-Ruey ; Liu, Ya-Ming .
    In: MPRA Paper.
    RePEc:pra:mprapa:35147.

    Full description at Econpapers || Download paper

  18. Regulation and Welfare: Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry. (2011). Higgins, Matthew ; Chatterjee, Chirantan ; Branstetter, Lee G..
    In: NBER Working Papers.
    RePEc:nbr:nberwo:17188.

    Full description at Econpapers || Download paper

  19. The Impact of Government Procurement Composition on Private R&D Activities. (2011). Wiederhold, Simon ; Slavtchev, Viktor.
    In: Jena Economic Research Papers.
    RePEc:jrp:jrpwrp:2011-036.

    Full description at Econpapers || Download paper

  20. Understanding R&D Policy: Efficiency or Politics?. (2011). Perez Sebastian, Fidel ; Perez-Sebastian, Fidel.
    In: Working Papers. Serie AD.
    RePEc:ivi:wpasad:2011-17.

    Full description at Econpapers || Download paper

  21. Opportunities and benefits as determinants of the direction of scientific research. (2011). Packalen, Mikko ; Bhattacharya, Jay.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:30:y:2011:i:4:p:603-615.

    Full description at Econpapers || Download paper

  22. Investments in Pharmaceuticals Before and After TRIPS. (2011). Kyle, Margaret ; McGahan, Anita M.
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:8371.

    Full description at Econpapers || Download paper

  23. The effect of newer drugs on health spending: do they really increase the costs?. (2010). Köksal, Bülent ; Abdulkad&idot;r C&idot;van, ; Koksal, Bulent .
    In: Health Economics.
    RePEc:wly:hlthec:v:19:y:2010:i:5:p:581-595.

    Full description at Econpapers || Download paper

  24. Pharmaceutical penetration of new drug and pharmaceutical market structure in Taiwan: hospital-level prescription of thiazolidinediones for diabetes. (2010). Huang, Weng-Foung ; Chen, Pei-Fen ; Kuo, Ken ; Shih, Hsin-Wei ; Lee, Yue-Chune ; Wen, Yu-Wen ; Tsai, Yi-Wen.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:11:y:2010:i:3:p:279-290.

    Full description at Econpapers || Download paper

  25. Complements and potential competition. (2010). Packalen, Mikko.
    In: International Journal of Industrial Organization.
    RePEc:eee:indorg:v:28:y:2010:i:3:p:244-253.

    Full description at Econpapers || Download paper

  26. Investments in Pharmaceuticals Before and After TRIPS. (2009). Kyle, Margaret ; McGahan, Anita .
    In: NBER Working Papers.
    RePEc:nbr:nberwo:15468.

    Full description at Econpapers || Download paper

  27. Induced Innovation and Social Inequality: Evidence from Infant Medical Care. (2009). Richards-Shubik, Seth ; Cutler, David ; Meara, Ellen .
    In: NBER Working Papers.
    RePEc:nbr:nberwo:15316.

    Full description at Econpapers || Download paper

  28. Income and Health Spending: Evidence from Oil Price Shocks. (2009). Notowidigdo, Matthew ; Finkelstein, Amy ; Acemoglu, Daron.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:14744.

    Full description at Econpapers || Download paper

  29. Income and Health Spending: Evidence from Oil Price Shocks. (2009). Notowidigdo, Matthew ; Finkelstein, Amy ; Acemoglu, Daron.
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:7255.

    Full description at Econpapers || Download paper

  30. The Value of Life in General Equilibrium. (2008). Sun, Eric ; Philipson, Tomas ; Mulligan, Casey ; Jena, Anupam.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:14157.

    Full description at Econpapers || Download paper

  31. The Other Ex-Ante Moral Hazard in Health. (2008). Packalen, Mikko ; Bhattacharya, Jay.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:13863.

    Full description at Econpapers || Download paper

  32. Is Medicine an Ivory Tower? Induced Innovation, Technological Opportunity, and For-Profit vs. Non-Profit Innovation. (2008). Packalen, Mikko ; Bhattacharya, Jay.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:13862.

    Full description at Econpapers || Download paper

  33. The Impact of Medicare Part D on Pharmaceutical R&D. (2008). Sood, Neeraj ; Blume-Kohout, Margaret.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:13857.

    Full description at Econpapers || Download paper

  34. The Supply Side of Innovation: H-1B Visa Reforms and US Ethnic Invention. (2008). Lincoln, William ; Kerr, William.
    In: Harvard Business School Working Papers.
    RePEc:hbs:wpaper:09-005.

    Full description at Econpapers || Download paper

  35. Regulatory policy, value of knowledge assets and innovation strategy: The case of the Orphan Drug Act. (2008). Rzakhanov, Zaur .
    In: Research Policy.
    RePEc:eee:respol:v:37:y:2008:i:4:p:673-689.

    Full description at Econpapers || Download paper

  36. Growth leaders. (2008). Etro, Federico.
    In: Journal of Macroeconomics.
    RePEc:eee:jmacro:v:30:y:2008:i:3:p:1148-1172.

    Full description at Econpapers || Download paper

  37. Market incentives and pharmaceutical innovation. (2008). Yin, Wesley.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:27:y:2008:i:4:p:1060-1077.

    Full description at Econpapers || Download paper

  38. A primer on the economics of re-importation of prescription drugs. (2007). Berndt, Ernst R..
    In: Managerial and Decision Economics.
    RePEc:wly:mgtdec:v:28:y:2007:i:4-5:p:415-435.

    Full description at Econpapers || Download paper

  39. If it aint broke, dont price fix it: the OFT and the PPRS. (2007). Towse, Adrian.
    In: Health Economics.
    RePEc:wly:hlthec:v:16:y:2007:i:7:p:653-665.

    Full description at Econpapers || Download paper

  40. The Welfare Effects of Public Drug Insurance. (2007). Sood, Neeraj ; Lakdawalla, Darius.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:13501.

    Full description at Econpapers || Download paper

  41. Is it possible to have cheaper drugs and preserve the incentive to innovate? The benefits of privatizing the drug approval process. (2007). Sauer, Robert.
    In: The Journal of Technology Transfer.
    RePEc:kap:jtecht:v:32:y:2007:i:5:p:509-524.

    Full description at Econpapers || Download paper

  42. Demographics and Industry Returns. (2007). DellaVigna, Stefano ; Della Vigna, Stefano ; Pollet, Joshua M..
    In: American Economic Review.
    RePEc:aea:aecrev:v:97:y:2007:i:5:p:1667-1702.

    Full description at Econpapers || Download paper

  43. Wants and Past Knowledge: Growth Cycles with Emerging Industries. (2006). Horii, Ryo.
    In: Development and Comp Systems.
    RePEc:wpa:wuwpdc:0504007.

    Full description at Econpapers || Download paper

  44. Wants and Past Knowledge: Growth Cycles with Emerging Industries. (2006). Horii, Ryo.
    In: Discussion Papers in Economics and Business.
    RePEc:osk:wpaper:0603.

    Full description at Econpapers || Download paper

  45. Did Medicare Induce Pharmaceutical Innovation?. (2006). Linn, Joshua ; Finkelstein, Amy ; Acemoglu, Daron ; Cutler, David.
    In: Scholarly Articles.
    RePEc:hrv:faseco:2664267.

    Full description at Econpapers || Download paper

  46. Innovation and competitive pressure. (2006). Vives, Xavier.
    In: IESE Research Papers.
    RePEc:ebg:iesewp:d-0634.

    Full description at Econpapers || Download paper

  47. Procuring Innovation. (2006). Spagnolo, Giancarlo ; Denicolo', Vincenzo ; Cozzi, Guido ; Cabral, Luis ; Zanza, Matteo.
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:5774.

    Full description at Econpapers || Download paper

  48. Income Distribution and Demand-Induced Innovations. (2005). Zweimüller, Josef ; Foellmi, Reto.
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:4985.

    Full description at Econpapers || Download paper

  49. Innovation and Competitive Pressure. (2005). Vives, Xavier.
    In: Department of Economics, Working Paper Series.
    RePEc:cdl:econwp:qt1s1059vr.

    Full description at Econpapers || Download paper

  50. Income Distribution and Demand-induced Innovations. (). Zweimüller, Josef ; Foellmi, Reto.
    In: IEW - Working Papers.
    RePEc:zur:iewwpx:212.

    Full description at Econpapers || Download paper

Coauthors

Authors registered in RePEc who have wrote about the same topic

Report date: 2025-02-16 01:57:54 || Missing content? Let us know

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated October, 6 2023. Contact: CitEc Team.